Amblyopia clinical trials
15 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Binocular Amblyopia Treatment
- Novel Amblyopia Treatment With Virtual Reality Games
- A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
- Patch-free Occlusion Therapy
- Valproate for the Treatment of Residual Amblyopia
- Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
- Establishing New Treatment Approaches for Amblyopia: Perceptual Learning and Video Games
- Amblyopia Treatment for Children Aged 8 to 12 Years
- Noninvasive Brain Stimulation in Adult Amblyopia
- Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
- Video Treatment for Amblyopia
- Clinical Data Registry of Amblyopia Patients on Luminopia Treatment
- Visual Function Abnormalities in Strabismus and Amblyopia and Response to Therapy
- Evaluation of Echothiophate in Pediatric Patients With Refractory Amblyopia
- OCT Eccentric Fixation and Amblyopia in Children
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Amblyopia” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.